Stock Movers BP Rises, Raiffeisen Dips, Abivax Gains
Apr 9, 2026
Louise Moon, Breaking News editor at Bloomberg who covers European stocks and M&A. She talks about oil-driven rebounds lifting energy names like BP. She outlines Raiffeisen’s €450m offer for Addiko and its wider M&A push. She also covers a biotech upgrade that sent Abivax shares higher.
AI Snips
Chapters
Transcript
Episode notes
Oil Majors Drive FTSE On Price Rebound
- BP and other European oil majors rose after oil prices rebounded following yesterday's drop.
- Louise Moon said BP gained over 2% and, along with Shell, became the biggest positive contributors to the FTSE due to their index weight.
Raiffeisen's Second Big Acquisition This Year
- Raiffeisen offered to buy Addiko Bank in a deal valuing it at about €450 million and priced at an 11% discount to yesterday's close.
- Louise Moon noted Raiffeisen recently bought BBVA's Romanian unit for nearly €600 million and this would be its second major acquisition this year.
Abivax Upside From Crohn's Opportunity
- Abivax shares rose as much as 3.8% after Oddo BHF upgraded the stock, citing larger-than-expected Crohn's disease potential.
- Oddo now models peak sales of €2.8 billion in 2034 versus €2 billion previously, and upcoming 2024 trial readouts make the stock pivotal.